VP of Research & Policy, Ewing Marion Kauffman Foundation
Professor, Michigan State University
Vice president, chief strategy and operating officer of the Texas Medical Center
Managing Director, D.E. Shaw and Co., L.P.
|BIO 2014: Antisense and Disruptive Technologies for Drug Discovery||Stanley Crooke||06/23/14||San Diego|
|FDA OKs Changes in Santarus Heart Study||Bruce V. Bigelow||08/04/11||San Diego|
|Halozyme Licensing Deal Valued at $63M||Bruce V. Bigelow||06/08/11||San Diego|
|Page 1 of 1|